Jump to content
RemedySpot.com

Research at UCI

Rate this topic


Guest guest

Recommended Posts

Translational Research

Wen-Hwa Lee, PhD - 2008 (Active) - 6097-08

Department of Biological Chemistry, University of California at Irvine, >

Irvine, CA US

Developing IBR Compounds as Rad51 Recombinase Inhibitors for Leukemia

Treatment

Imatinib, a potent inhibitor of Bcr-Abl has been successful in treating CML

patients but faces two major obstacles. One is the persistence of

Bcr-Abl-positive stem cells, which may require long-term imatinib therapy.

The other is relapse of the disease due to the emergence of resistance to

imatinib. It is hypothesized that combining a Bcr-Abl tyrosine kinase

inhibitor with inhibitors of critical downstream effectors could

significantly improve CML treatment. Rad51 recombinase, an essential

protein for cell proliferation, is a key downstream target of Bcr-Abl

kinase, which enhances Rad51 expression through Stat5 as well as activates

Rad51 through phosphorylation. We have discovered a novel Rad51 inhibitor,

IBR2 that inhibits Rad51 multimerization and activates Rad51 degradation.

IBR2 synergizes with imatinib in treating K562 cells as well as Ba/F3-p210

cells. Remarkably, this

compound alone induces apoptosis of Ba/F3 cells with imatinib-resistant

T315I mutant and significantly prolonged the lifespan of mice carrying

Ba/F3-T315I cells.

In this application, we plan to generate more effective IBR2 analogues to

improve the efficacy of treating CML and acute myeloid leukemia (AML)

because 70% of AML have an activated Stat5 that enhances Rad51 expression.

It is anticipated that this newly discovered Rad51 inhibitor would be

beneficial in treating these leukemias.

Zavie (age 69)

67 Shoreham Avenue

Ottawa, Canada, K2G 3X3

dxd AUG/99

INF OCT/99 to FEB/00, CHF

No meds FEB/00 to JAN/01

Gleevec since MAR/27/01 (400 mg)

CCR SEP/01. #102 in Zero Club

2.8 log reduction Sep/05

3.0 log reduction Jan/06

2.9 log reduction Feb/07

3.2 log reduction Jun/07

3.6 log reduction Sep/07

e-mail: zmiller@...

Tel: 613-726-1117

Fax: 309-296-0807

Cell: 613-202-0204

ID: zaviem

Link to comment
Share on other sites

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
×
  • Create New...